The NIH is providing the money under a recently launched initiative to advance genome editing in humans, with an eye toward therapeutic applications.
The funding from the Mark Foundation for Cancer Research will support an initiative to investigate cancer genomics in ethnically diverse populations.
The agency is seeking one or two sequencing centers for the Gabriella Miller Kids First Research Program.
Qiagen and Health Innovation Manchester will create a genomics campus in the district anchored by a diagnostics development hub.
The partners will test PerkinElmer's Vanadis NIPT platform on samples from 2,650 women to determine detection and false positive rates.
The grant will support the consortium's ongoing efforts to clinically validate data analysis software for monitoring treatment responses to cancer vaccines.
The synthesis method will be incorporated into the silicon array the company developed to produce DNA at scale.
The project will investigate the use of whole-genome sequencing within the California Medical Assistance program.
The funding will help support the whole-genome and RNA sequencing of Alzheimer's disease patients to advance biomarker development.
The company said it will use the funding to accelerate the development of an affordable sequencing test for metagenomic samples.
The subcommittee called for $2 billion to be added to the NIH's budget next year, increasing it to $39.1 billion.
Businesses can now apply for a share of the funds to develop new technologies that increase the UK's capacity to carry out genomic analysis.
The proposed bill would increase the National Institutes of Health's budget from roughly $37.1 billion to $38.3 billion in fiscal 2019.
Fifteen years after the Human Genome Project was declared completed, genomic medicine is beginning to be implemented, sooner than Green and others had expected.
Researchers can apply to receive $100,000 in matched funds from Intermountain to cover project costs related to high-throughput genomic sequencing.
The Somatic Cell Genome Editing program was established earlier this year to help remove barriers from the adoption of genome editing for treating patients.
In exchange, Editas has the exclusive right to be the first to negotiate for licenses to genome-editing inventions that arise from the sponsored research.
With the release of its Q Exactive UHMR system and a new $130 million NIH program, the company sees opportunity to expand use of its cryo-EM and mass spec techs.
The company's software platform is designed to help users use next-generation sequencing data to better understand intratumor heterogeneity.
The system is designed to identify intact secondary metabolite gene clusters for natural product discovery in a fungal model organism.
The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.
Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.
In Science this week: in vitro generation of human reproductive cells, and more.
Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.